Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million

Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, July 11, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/tjlw9k/immunoprotein) has announced the addition of the "Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

The market for immunoprotein diagnostic testing has been segmented according to immunoprotein types which include immunoglobulins, complement system proteins, C-reactive protein (CRP), haptoglobin, prealbumin and free light chains (FLC) of immunoglobulins. The market has also been segmented according to application in diagnosis of various diseases such as infectious diseases, allergy testing, endocrine testing, oncology testing, toxicology testing, and autoimmune disease testing.

Further, the market has been studied from the perspective of technology platforms such as enzyme linked immunosorbent assay (ELISA), chemiluminescence assay, immunofluorescence assay, immunoturbidity assay, radioimmunoassay, and immunoprotein electrophoresis. Geographically, the market has been segmented into four major regions, namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW).

Each of the segments has been analyzed on the basis of current and future market size for the period 2011 to 2019, in terms of revenue (USD million), considering 2011 and 2012 as the base years.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Global Immunoprotein Diagnostic Testing Market Overview

Chapter 4 Global Immunoprotein Diagnostic Testing Market, by Assay Technology

Chapter 5 Global Immunoprotein Diagnostic Testing Market, by Immunoprotein Type

Chapter 6 Global Immunoprotein Diagnostic Testing Market, by Application

Chapter 7 Global Immunoprotein Diagnostic Testing Market, by Geography

Chapter 8 Recommendations

Chapter 9 Company Profiles

Companies Mentioned:

  • Abbott Laboratories, Inc.
  • Abcam PLC
  • DiaSorin SPA
  • Enzo Life Sciences, Inc.
  • Fujirebio Diagnostics, Inc.
  • Omega Diagnostics Group PLC
  • Randox Laboratories Ltd.
  • Roche Holding AG
  • Siemens AG
  • The Binding Site Group Ltd.
  • Thermo Fisher Scientific, Inc.

For more information visit http://www.researchandmarkets.com/research/tjlw9k/immunoprotein

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

©2012 PR Newswire. All Rights Reserved.